Cabaletta Bio | Investor Presentation Deck | 23 slides · page 10 of 23
The slide highlights clinical efficacy and safety data from a Nature Medicine study (Mackensen et al., 2022) relevant to the company's CABA-201 construct.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
chart 2/2 disclaimer 1/1 list 4/4 title 2/2
Components 9
bar-grouped line disclaimer bullet bullet bullet bullet headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.